Repligen Corporation (RGEN): Price and Financial Metrics

RGEN POWR Grades

• RGEN scores best on the Quality dimension, with a Quality rank ahead of 59.56% of US stocks.
• The strongest trend for RGEN is in Growth, which has been heading down over the past 177 days.
• RGEN ranks lowest in Growth; there it ranks in the 2nd percentile.

RGEN Stock Summary

• The price/operating cash flow metric for REPLIGEN CORP is higher than 95.16% of stocks in our set with a positive cash flow.
• Of note is the ratio of REPLIGEN CORP's sales and general administrative expense to its total operating expenses; 98.2% of US stocks have a lower such ratio.
• With a price/sales ratio of 12.3, REPLIGEN CORP has a higher such ratio than 92.44% of stocks in our set.
• Stocks that are quantitatively similar to RGEN, based on their financial statements, market capitalization, and price volatility, are ROG, SLP, NTIC, ALGN, and ATRI.
• Visit RGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.repligen.com.

RGEN Valuation Summary

• In comparison to the median Healthcare stock, RGEN's EV/EBIT ratio is 554.82% higher, now standing at 64.5.
• Over the past 243 months, RGEN's price/sales ratio has gone down 4.3.

Below are key valuation metrics over time for RGEN.

RGEN Growth Metrics

The 5 year net income to common stockholders growth rate now stands at 76.56%.
• Its 4 year net income to common stockholders growth rate is now at 76.56%.
• The 3 year cash and equivalents growth rate now stands at 198.08%.

RGEN's revenue has moved up $617,834,000 over the prior 52 months.

The table below shows RGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	801.536	172.083	185.959
2022-09-30	801.295	159.821	166.34
2022-06-30	778.77	140.937	159.433
2022-03-31	734.097	132.867	145.805
2021-12-31	670.534	119.016	128.291
2021-09-30	592.661	84.267	118.879

RGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RGEN has a Quality Grade of C, ranking ahead of 39.46% of graded US stocks.
• RGEN's asset turnover comes in at 0.293 -- ranking 157th of 682 Pharmaceutical Products stocks.
• ORMP, MESO, and AWH are the stocks whose asset turnover ratios are most correlated with RGEN.

The table below shows RGEN's key quality metrics over time.